{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:02:34Z","timestamp":1791068554390,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.autrev.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T02:01:36Z","timestamp":1317607296000},"page":"335-340","source":"Crossref","is-referenced-by-count":54,"title":["Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: A single centre study and review of the literature"],"prefix":"10.1016","volume":"11","author":[{"given":"Francesca","family":"Ingegnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Lubatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ingegnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Boracchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/BOR.0b013e32833f1970","article-title":"Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls","volume":"22","author":"Labirua","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.bor.0000179949.65895.53","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"17","author":"Fathi","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2011.09.007_bb0345","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1191\/0961203305lu2158oa","article-title":"Polymyositis\/dermatomyositis-associated lung disease: analysis of a series of 81 patients","volume":"14","author":"Selva-O'Callaghan","year":"2005","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0020","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","article-title":"The geoepidemiology of autoimmune muscle disease","volume":"9","author":"Prieto","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2011.09.007_bb0350","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.autrev.2011.05.021","article-title":"Idiopathic inflammatory myopathies: definition and management of refractory disease","volume":"10","author":"Brand\u00e3o","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2011.09.007_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2340\/00015555-0177","article-title":"Predicting factors of interstitial lung disease in dermatomyositis and polymyositis","volume":"87","author":"Chen","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0035","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0355","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","article-title":"Interstitial lung disease in systemic sclerosis","volume":"10","author":"Bussone","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCP.0b013e32833cc997","article-title":"The role of high-resolution computed tomography in the work-up of interstitial lung disease","volume":"16","author":"Verschakelen","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"10.1016\/j.autrev.2011.09.007_bb0360","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1164\/rccm.200402-147OC","article-title":"Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?","volume":"170","author":"Flaherty","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2011.09.007_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2003-42371","article-title":"High-resolution computed tomography in the diagnosis of diffuse lung disease: a clinical perspective","volume":"24","author":"Wells","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2011.09.007_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11926-008-0053-2","article-title":"Autoantibodies and their significance in myositis","volume":"10","author":"Targoff","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"282","key":"10.1016\/j.autrev.2011.09.007_bb0065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"issue":"8","key":"10.1016\/j.autrev.2011.09.007_bb0070","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/art.22790","article-title":"Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis","volume":"56","author":"Levine","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2177\/jsci.30.444","article-title":"Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis\/dermatomyositis and related conditions","volume":"30","author":"Hirakata","year":"2007","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.autrev.2011.09.007_bb0365","article-title":"Pathogenesis and therapies of immune-mediated myopathies","author":"Dalakas","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0085","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","article-title":"Polymyositis, dermatomyositis and malignancy: a further intriguing link","volume":"9","author":"Zampieri","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2011.09.007_bb0090","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2010.05.020","article-title":"Anti-Ku antibodies: clinical, genetic and diagnostic insights","volume":"9","author":"Belizna","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2011.09.007_bb0095","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2003.006122","article-title":"Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis","volume":"63","author":"Fathi","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2011.09.007_bb0115","first-page":"1727","article-title":"Novel autoantibodies against 7SL RNA in patients with polymyositis\/dermatomyositis","volume":"32","author":"Satoh","year":"2005","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.00104310","article-title":"Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies","volume":"37","author":"Hervier","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.autrev.2011.09.007_bb0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780310408","article-title":"Antibody to threonyl-transfer RNA synthetase in myositis sera","volume":"31","author":"Targoff","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s100670070030","article-title":"Clinical and serological aspects of patients with anti-Jo-1 antibodies \u2014 an evolving spectrum of disease manifestations","volume":"19","author":"Schmidt","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e3181b0e910","article-title":"Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience","volume":"15","author":"Mileti","year":"2009","journal-title":"J Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2011.09.007_bb0140","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","article-title":"Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients","volume":"29","author":"Vancsa","year":"2009","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0370","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.autrev.2008.12.001","article-title":"PM1-Alpha ELISA: the assay of choice for the detection of anti-PM\/Scl autoantibodies?","volume":"8","author":"Mahler","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"16","key":"10.1016\/j.autrev.2011.09.007_bb0375","first-page":"508","article-title":"Anti-synthetase syndrome: a special subgroup of idiopathic inflammatory myopathies. Apropos of 3 case reports","volume":"85","author":"Perret","year":"1996","journal-title":"Praxis (Bern 1994)"},{"issue":"8","key":"10.1016\/j.autrev.2011.09.007_bb0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.autrev.2011.09.007_bb0165","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2011.09.007_bb0380","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","article-title":"This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","author":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.autrev.2011.09.007_bb0175","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.24631","article-title":"Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease","volume":"60","author":"Richards","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2011.09.007_bb0180","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis-dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.autrev.2011.09.007_bb0185","first-page":"68","article-title":"Anti Jo-1 myositis. Mechanic's hands and interstitial lung disease","volume":"71","author":"Taggart","year":"2002","journal-title":"Ulster Med J"},{"issue":"7","key":"10.1016\/j.autrev.2011.09.007_bb0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00415-004-0449-5","article-title":"The long-term outcome of anti-Jo-1-positive inflammatory myopathies","volume":"251","author":"Spath","year":"2004","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.autrev.2011.09.007_bb0195","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/rheumatology\/keh723","article-title":"Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis","volume":"44","author":"Kang","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","article-title":"Clinical implications of autoantibody screening in patients with autoimmune myositis","volume":"39","author":"Ghirardello","year":"2006","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08916930600622884","article-title":"Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies","volume":"39","author":"Yoshifuji","year":"2006","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.autrev.2011.09.007_bb0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","article-title":"Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis","volume":"46","author":"Yamasaki","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0220","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel435","article-title":"Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies","volume":"46","author":"Sato","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0225","first-page":"1012","article-title":"Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis","volume":"34","author":"Matsushita","year":"2007","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2011.09.007_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.autrev.2011.09.007_bb0390","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/art.22860","article-title":"A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies","volume":"56","author":"Eloranta","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0720-048X(03)00094-9","article-title":"Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis","volume":"49","author":"Bonnefoy","year":"2004","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.autrev.2011.09.007_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1465-9921-6-96","article-title":"Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis","volume":"6","author":"De Santis","year":"2005","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0250","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.autrev.2011.09.007_bb0395","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","article-title":"Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies","volume":"41","author":"Dugar","year":"2011","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0260","first-page":"202","article-title":"Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome","volume":"59","author":"Franzolini","year":"2007","journal-title":"Reumatismo"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/08916930600623874","article-title":"Anti-Jo-1 antibody positive polymyositis \u2014 successful therapy with leflunomide","volume":"39","author":"Lange","year":"2006","journal-title":"Autoimmunity"},{"issue":"7","key":"10.1016\/j.autrev.2011.09.007_bb0270","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie","year":"1998","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2011.09.007_bb0275","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome: a retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2011.09.007_bb0400","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.24683","article-title":"Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells","volume":"60","author":"Barbasso Helmers","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.09.007_bb0285","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.23571","article-title":"Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology","volume":"59","author":"Fathi","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2011.09.007_bb0290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00004728-200001000-00005","article-title":"Pulmonary fat embolism syndrome: CT findings in six patients","volume":"24","author":"Arakawa","year":"2000","journal-title":"J Comput Assist Tomogr"},{"issue":"10","key":"10.1016\/j.autrev.2011.09.007_bb0295","first-page":"1520","article-title":"High resolution computed tomography in early scleroderma lung disease","volume":"18","author":"Warrick","year":"1991","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0300","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/08916930600623767","article-title":"Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies","volume":"39","author":"Mielnik","year":"2006","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0305","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.21883","article-title":"Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis\/dermatomyositis","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2011.09.007_bb0310","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","article-title":"Treatment of antisynthetase-associated interstitial lung disease with tacrolimus","volume":"52","author":"Wilkes","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2011.09.007_bb0315","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.09.007_bb0405","article-title":"Therapeutic blockade of TNF in patients with SLE-Promising or crazy?","author":"Aringer","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2011.09.007_bb0325","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.autrev.2011.04.025","article-title":"Systemic sclerosis refractory disease: from the skin to the heart","volume":"10","author":"Almeida","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.09.007_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2011.06.007","article-title":"Therapy of polymyositis and dermatomyositis","author":"Marie","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2011.09.007_bb0415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-010-8238-7","article-title":"Cutting edge issues in polymyositis","volume":"41","author":"Ghirardello","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2011.09.007_bb0340","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","article-title":"Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application","volume":"10","author":"Danieli","year":"2011","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T12:57:28Z","timestamp":1543496248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1568997211002060"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.09.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}